BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 11792276)

  • 21. [Fulminant liver failure with a fatal outcome due to flutamide].
    Fernández Peña CM; Morano Amado LE; Montes Santiago J; Fachal C
    Med Clin (Barc); 1997 Feb; 108(6):237-8. PubMed ID: 9102495
    [No Abstract]   [Full Text] [Related]  

  • 22. [A case of fulminant hepatitis caused by antiandrogen, flutamide in a patient with prostate cancer].
    Satoh T; Egawa S; Katsuta M; Iwamura M; Uchida T; Koshiba K
    Nihon Hinyokika Gakkai Zasshi; 1997 Jul; 88(7):694-6. PubMed ID: 9267134
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interstitial pneumonitis related to leuprorelin acetate and flutamide.
    Azuma T; Kurimoto S; Mikami K; Oshi M
    J Urol; 1999 Jan; 161(1):221. PubMed ID: 10037405
    [No Abstract]   [Full Text] [Related]  

  • 24. [Flutamide and pseudoporphyria].
    Schmutz JL; Barbaud A; Tréchot P
    Ann Dermatol Venereol; 1999 Apr; 126(4):374. PubMed ID: 10421946
    [No Abstract]   [Full Text] [Related]  

  • 25. [Changes in liver function induced by flutamide in patients with prostate cancer (studies in patients treated with total androgen blockage)].
    Ikemoto I; Ohishi Y; Yamazaki H; Wada T; Aizawa Y
    Nihon Hinyokika Gakkai Zasshi; 2000 Jun; 91(6):556-61. PubMed ID: 10897581
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Flutamide-induced photosensitivity: is it a forme fruste of lupus?
    Kaur C; Thami GP
    Br J Dermatol; 2003 Mar; 148(3):603-4. PubMed ID: 12653768
    [No Abstract]   [Full Text] [Related]  

  • 27. [Toxic hepatitis caused by flutamide].
    Cuevas Campos MA; Pareja Llorens G; García Romero E; Bertomeu Blanch F
    Gastroenterol Hepatol; 1998 Dec; 21(10):499-500. PubMed ID: 9927799
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical utility of ursodeoxycholic acid in preventing flutamide-induced hepatopathy in patients with prostate cancer: a preliminary study.
    Kojima M; Kamoi K; Ukimura O; Fujito A; Nakao M; Tanaka S; Miyashita H; Iwamoto N; Ohe H; Kitamori T; Date S; Kitamura K; Araki H; Aoki T; Imada N; Takada H; Imaide Y; Mikami K; Uchida M; Saitoh M; Miki T
    Int J Urol; 2002 Jan; 9(1):42-6. PubMed ID: 11972649
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Flutamide-induced liver injury: a case report.
    Chu CW; Hwang SJ; Luo JC; Tsay SH; Li CP; Huang YS; Chang FY; Lee SD
    Zhonghua Yi Xue Za Zhi (Taipei); 1998 Nov; 61(11):678-82. PubMed ID: 9872026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute cholestatic hepatitis secondary to flutamide therapy.
    Prattichizzo FA
    Am J Med; 1994 Apr; 96(4):392-3. PubMed ID: 8166163
    [No Abstract]   [Full Text] [Related]  

  • 31. Flutamide-induced hepatotoxicity with possible potentiation by simvastatin.
    Ashar U; Desai D; Bhaduri A
    J Assoc Physicians India; 2003 Jan; 51():75-7. PubMed ID: 12693464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Flutamide-induced hepatic disorder and serum concentrations of flutamide and its metabolites in patients with prostate cancer].
    Nakagawa Y; Koyama M; Matsumoto M
    Hinyokika Kiyo; 1999 Dec; 45(12):821-6. PubMed ID: 10659414
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microscopic polyangiitis complicated by the development of prostate cancer and flutamide-induced hepatitis.
    Papaioannides D; Korantzopoulos P; Bouropoulos C; Latsi P; Fotinou M; Orphanidou D
    Int Urol Nephrol; 2005; 37(3):515-20. PubMed ID: 16307333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interstitial pneumonitis related to flutamide monotherapy for prostate cancer.
    Nomura M; Sato H; Fujimoto N; Matsumoto T
    Int J Urol; 2004 Sep; 11(9):798-800. PubMed ID: 15379950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recommended dose of flutamide with LH-RH agonist therapy in patients with advanced prostate cancer.
    Akaza H; Isaka S; Usami M; Kanetake H; Kotake T; Koiso K; Aso Y
    Int J Urol; 1996 Nov; 3(6):468-71. PubMed ID: 9170575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Flutamide-associated liver toxicity during treatment with total androgen suppression and radiation therapy for prostate cancer.
    Rosenthal SA; Linstadt DE; Leibenhaut MH; Andras EJ; Brooks CP; Stickney DR; Chang GC; Wolkov HB; Gilbert RM
    Radiology; 1996 May; 199(2):451-5. PubMed ID: 8668793
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Photosensitive drug eruption induced by flutamide.
    Yokote R; Tokura Y; Igarashi N; Ishikawa O; Miyachi Y
    Eur J Dermatol; 1998 Sep; 8(6):427-9. PubMed ID: 9729061
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Editorial comment on: Cardiovascular mortality and duration of androgen deprivation for locally advanced prostate cancer: analysis of RTOG 92-02.
    Whelan P
    Eur Urol; 2008 Oct; 54(4):823-4. PubMed ID: 18243509
    [No Abstract]   [Full Text] [Related]  

  • 39. Involvement of Th2 cytokines in the mouse model of flutamide-induced acute liver injury.
    Higuchi S; Kobayashi M; Yano A; Tsuneyama K; Fukami T; Nakajima M; Yokoi T
    J Appl Toxicol; 2012 Oct; 32(10):815-22. PubMed ID: 21735453
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fulminant hepatitis after flutamide treatment.
    Dourakis SP; Alexopoulou AA; Hadziyannis SJ
    J Hepatol; 1994 Mar; 20(3):350-3. PubMed ID: 8014445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.